On November 25, Zhende Medical held its third quarter earnings conference. The director and general manager of the company, Lu Jianguo, stated that the current U.S. tariff policy has no impact on the company, and the company will continue to actively monitor various external changes and respond positively. Regarding external development, while focusing on internal growth, the company will continue to center around the core business area of 'medical + health' and actively seek external expansion opportunities. First, fully leverage the professional capabilities and platform advantages of the Shaoxing Guochuang Zhende Medical Industry Phase I Private Equity Investment Partnership Enterprise (limited partnership) Industry Fund and its sub-funds to explore more industry investment opportunities. Second, guided by meeting the needs and pain points of clinical and consumer customers, and combining the characteristics of current domestic and foreign policies and market development, the company will continue to pursue industry integration opportunities, improve product portfolio, and enhance market competitiveness.